Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem-Like Cells

Heat shock protein DNAJB8 is a novel target for immunotherapy of colon cancer-initiating cells

(2014) Rena Morita et al.   CANCER SCIENCE

Overexpressed oncogenic tumor-self antigens

(2014) Robert K Bright et al.   Human Vaccines & Immunotherapeutics

A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer

(2013) Daniela Fenoglio et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Keratin 19: a key role player in the invasion of human hepatocellular carcinomas

(2013) Olivier Govaere et al.   GUT

Cytotoxic T lymphocytes: the future of cancer stem cell eradication?

(2013) Hiroshi Saijo et al.   Immunotherapy

Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma

(2013) Qiu-Zhong Pan et al.   MOLECULAR CARCINOGENESIS

Identifying Resistance Mechanisms against Five Tyrosine Kinase Inhibitors Targeting the ERBB/RAS Pathway in 45 Cancer Cell Lines

(2013) Zsófia Pénzváltó et al.   PLoS One

Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma

(2012) Mary Maluccio et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

(2012) Jeffrey A. Magee et al.   CANCER CELL

Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma

(2012) Terence Kin Wah Lee et al.   CANCER LETTERS

The role of annexin A3 playing in cancers

(2012) Na Wu et al.   Clinical & Translational Oncology

Annexin A2 is a new antigenic target for pancreatic cancer immunotherapy

(2012) Lei Zheng et al.   OncoImmunology

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies

(2011) Yin Wang et al.   Cell Stem Cell

Human hepatocellular carcinomas with “Stemness”-related marker expression: keratin 19 expression and a poor prognosis

(2011) Haeryoung Kim et al.   HEPATOLOGY

CD133+ liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling

(2011) Kwan Ho Tang et al.   HEPATOLOGY

Hypoxia Increases the Expression of Stem-Cell Markers and Promotes Clonogenicity in Glioblastoma Neurospheres

(2010) Eli E. Bar et al.   AMERICAN JOURNAL OF PATHOLOGY

Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells

(2010) Jian-cong Sun et al.   CANCER BIOLOGY & THERAPY

miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1

(2010) Stephanie Ma et al.   Cell Stem Cell

Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells

(2010) Yoshihiko Hirohashi et al.   Immunotherapy

Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells

(2010) Desheng Weng et al.   INTERNATIONAL JOURNAL OF CANCER

Interaction of Hypoxia-Inducible Factor-1α and Notch Signaling Regulates Medulloblastoma Precursor Proliferation and Fate

(2010) Francesca Pistollato et al.   STEM CELLS

mTOR Signal and Hypoxia-Inducible Factor-1  Regulate CD133 Expression in Cancer Cells

(2009) K. Matsumoto et al.   CANCER RESEARCH

PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium

(2009) Huaiyu Mi et al.   NUCLEIC ACIDS RESEARCH

Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α

(2009) A Soeda et al.   ONCOGENE

Antigen-Specific T-Cell Response from Dendritic Cell Vaccination Using Cancer Stem-Like Cell-Associated Antigens

(2009) Qijin Xu et al.   STEM CELLS

Molecular Characterization of Cultured Adult Human Liver Progenitor Cells

(2009) Justyna Jozefczuk et al.   TISSUE ENGINEERING PART C-METHODS